Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2026, recommended Final Dividend of Rs. 2.90 per equity share.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care Limited reported strong FY2025-26 results with revenue from operations growing 11.2% to Rs 50,255.27 lakhs from Rs 45,181.63 lakhs in FY2024-25. Profit after tax increased 13.9% to Rs 5,791.78 lakhs from Rs 5,083.47 lakhs. Basic and diluted EPS rose to Rs 20.03 from Rs 17.58. The Board recommended a Final Dividend of Rs 2.90 per equity share (face value Rs 1) for FY2025-26, subject to shareholder approval at AGM. The company also appointed Mr. Ramaswami Krishnan as Additional Non-Executive Independent Director and re-appointed Mr. Muralidharan Swayambunathan for another 5-year term. Additionally, the Board approved rolling out the revised ESOP Phase 2 scheme. The statutory auditors issued an unmodified opinion on the financial results.
The 14% growth in PAT and improved EPS indicate healthy operational performance. The dividend of Rs 2.90 per share offers a reasonable return to shareholders. The appointments strengthen board governance. Overall, these results should be viewed positively by investors given the consistent growth trajectory and clean audit opinion.